SoftBank-backed Big Health is partneringwith CVS to launch a new medication targeting program to drive greater access to digital therapeutics for mental health and insomnia, the company tells Axios.
Why it matters: Underscored by the pandemic, mental health treatment faces a big volume and scale challenge.
